These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23106201)

  • 21. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconsidering IUDs.
    Goldberg B
    AVSC News; 1992 Jul; 30(2):7-8. PubMed ID: 12285571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
    Hohmann HL; Reeves MF; Chen BA; Perriera LK; Hayes JL; Creinin MD
    Contraception; 2012 Mar; 85(3):240-5. PubMed ID: 22067762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Today's IUDs offer safe, effective contraception.
    Finger WR
    Netw Res Triangle Park N C; 1993 Mar; 13(3):12-5. PubMed ID: 12318094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey of provider experience with misoprostol to facilitate intrauterine device insertion in nulliparous women.
    Ward K; Jacobson JC; Turok DK; Murphy PA
    Contraception; 2011 Dec; 84(6):594-9. PubMed ID: 22078188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of intrauterine devices in nulliparous women.
    Lohr PA; Lyus R; Prager S
    Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postplacental intrauterine device insertion at a teaching hospital.
    Jatlaoui TC; Marcus M; Jamieson DJ; Goedken P; Cwiak C
    Contraception; 2014 Jun; 89(6):528-33. PubMed ID: 24565735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine device developments.
    Netw Res Triangle Park N C; 1984; 5(4):4-6. PubMed ID: 12313225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Our experience with intrauterine devices (IUD) for birth control].
    Vidal JJ; Flores F; López de Medina R; Aisa E; Villar JM
    Acta Obstet Ginecol Hisp Lusit; 1980 Feb; 28(2):87-94. PubMed ID: 7395474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. User characteristics, experiences and continuation rates of copper intrauterine device use in a cohort of Australian women.
    Bateson D; Harvey C; Trinh L; Stewart M; Black KI
    Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):655-661. PubMed ID: 27704541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Anticipated Insertional Pain With Intrauterine Device Initiation.
    Narayan A; Sheeder J; Guiahi M
    J Adolesc Health; 2018 Jul; 63(1):37-42. PubMed ID: 30060855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levonorgestrel Intrauterine Device Use in Overweight and Obese Women.
    Saito-Tom LY; Soon RA; Harris SC; Salcedo J; Kaneshiro BE
    Hawaii J Med Public Health; 2015 Nov; 74(11):369-74. PubMed ID: 26568900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic inflammatory disease among women using copper IUDs, Progestasert, oral contraceptive pills or vaginal contraceptive pills: a 4-year prospective investigation.
    Larsson B; Rodau S; Patek E
    Contracept Deliv Syst; 1981 Jul; 2(3):237-42. PubMed ID: 12278910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
    Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
    Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure to insert a levonorgestrel-releasing intrauterine system: a survey based on self-reports by Israeli gynecologists.
    Ber A; Seidman DS
    Isr Med Assoc J; 2013 Mar; 15(3):163-5. PubMed ID: 23662379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postpartum insertion of modified intrauterine devices.
    Cole LP; Edelman DA; Potts DM; Wheeler RG; Laufe LE
    J Reprod Med; 1984 Sep; 29(9):677-82. PubMed ID: 6387112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IUDs: current perspectives.
    Hepburn S
    Curr Ther (Seaforth); 1994 Oct; 35(10):49-55. PubMed ID: 12319352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.